Infinity Pharmaceuticals Inc.

07/27/2021 | Press release | Distributed by Public on 07/27/2021 05:36

Infinity Pharmaceuticals Presents Updated Data from Phase 2 MARIO-275 Trial in Urothelial Cancer (UC) and Phase 2 MARIO-3 Trial in Triple Negative Breast Cancer (TNBC)